You may also like
A Novel Thrombelastograph® Tissue Factor/Kaolin Assay of Activated Clotting Times for Monitoring Heparin Anticoagulation During Cardiopulmonary Bypass
This study evaluates the thrombelastograph as a new assay of blood clotting times; it is activated by the addition of tissue clotting factor and kaolin and used to monitor heparin anticoagulation during cardiopulmonary bypass.
1 min read
In Honor of Woman’s History Month – LivaNova Presents an Interview with Tami Rosenthal, CCP, MBA, FPP
In recognition of Women’s History Month, the LivaNova Cardiovascular team would like to take a moment to honor the contributions and accomplishments of influential women in the healthcare profession.
1 min read
Experimental Device Developed By Percutaneous Valve Technologies May Provide Alternative to Open Heart Surgery
Percutaneous Valve Technologies, Inc. (PVT) — a privately held medical technology company engaged in the development of a breakthrough device for the […]
3 min read
